Testing effectiveness (Phase 2)Ended earlyNCT00281021
What this trial is testing
Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer
Who this might be right for
Carcinoma, Non-Small Cell Lung
University of Louisville 26
Showing 20 of 0 results